Watches of Switzerland Group PLC

BST:5WS Stock Report

Market Cap: €1.6b

Watches of Switzerland Group Valuation

Is 5WS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 5WS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 5WS (€6.8) is trading below our estimate of fair value (€11.95)

Significantly Below Fair Value: 5WS is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 5WS?

Key metric: As 5WS is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 5WS. This is calculated by dividing 5WS's market cap by their current earnings.
What is 5WS's PE Ratio?
PE Ratio32.7x
EarningsUK£41.00m
Market CapUK£1.34b

Price to Earnings Ratio vs Peers

How does 5WS's PE Ratio compare to its peers?

The above table shows the PE ratio for 5WS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average23.3x
DOU Douglas
25.6x25.4%€2.2b
FIE Fielmann Group
24.9x18.9%€3.5b
HBM HORNBACH Baumarkt
25.8xn/a€1.9b
CEC Ceconomy
16.9x35.8%€1.3b
5WS Watches of Switzerland Group
32.7x27.7%€1.3b

Price-To-Earnings vs Peers: 5WS is expensive based on its Price-To-Earnings Ratio (32.7x) compared to the peer average (23.3x).


Price to Earnings Ratio vs Industry

How does 5WS's PE Ratio compare vs other companies in the European Specialty Retail Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
5WS 32.7xIndustry Avg. 16.4xNo. of Companies12PE01020304050+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 5WS is expensive based on its Price-To-Earnings Ratio (32.7x) compared to the European Specialty Retail industry average (16.4x).


Price to Earnings Ratio vs Fair Ratio

What is 5WS's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

5WS PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio32.7x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 5WS's Price-To-Earnings Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 5WS forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentn/a
€6.54
0%
13.4%€8.01€5.46n/a11
Dec ’25n/a
€5.91
0%
13.5%€7.42€4.79n/a11
Nov ’25n/a
€5.93
0%
14.0%€7.62€4.80n/a11
Oct ’25€5.35
€5.95
+11.3%
14.7%€7.86€4.80n/a11
Sep ’25n/a
€5.85
0%
15.3%€7.77€4.74n/a11
Aug ’25n/a
€5.95
0%
15.3%€7.73€4.72n/a11
Jul ’25n/a
€5.92
0%
15.3%€7.73€4.72n/a11
Jun ’25€4.76
€5.55
+16.5%
13.3%€6.79€4.68n/a10
May ’25n/a
€5.62
0%
17.7%€7.65€4.32n/a11
Apr ’25n/a
€5.82
0%
15.9%€7.49€4.33n/a11
Mar ’25€4.76
€5.75
+20.8%
16.0%€7.49€4.33n/a12
Feb ’25€4.30
€6.98
+62.3%
33.3%€12.13€4.69n/a11
Jan ’25€7.90
€9.32
+17.9%
17.1%€12.06€6.41n/a11
Dec ’24€7.50
€9.11
+21.5%
17.0%€11.96€6.36n/a11
Nov ’24€5.65
€8.60
+52.2%
19.6%€12.17€6.32n/a11
Oct ’24€6.10
€9.17
+50.4%
17.3%€12.22€6.92€5.3511
Sep ’24€6.75
€10.31
+52.7%
19.7%€14.23€6.97n/a11
Aug ’24n/a
€11.00
0%
15.3%€14.23€8.13n/a11
Jul ’24n/a
€11.63
0%
13.4%€14.60€9.71n/a11
Jun ’24n/a
€11.63
0%
13.4%€14.60€9.71€4.7611
May ’24n/a
€13.20
0%
12.3%€15.86€10.71n/a10
Apr ’24n/a
€13.35
0%
11.4%€15.82€10.68n/a10
Mar ’24n/a
€13.48
0%
10.1%€15.78€11.22€4.769
Feb ’24n/a
€13.82
0%
11.7%€17.08€11.62€4.3010
Jan ’24n/a
€14.25
0%
11.5%€17.44€11.86€7.9010

Analyst Forecast: Target price is lower than the current share price.


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 08:40
End of Day Share Price 2024/12/05 00:00
Earnings2024/10/27
Annual Earnings2024/04/28

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Watches of Switzerland Group PLC is covered by 17 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Richard TaylorBarclays
Melania GrippoBNP Paribas Exane
Antoine BelgeBNP Paribas Exane